<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00788463</url>
  </required_header>
  <id_info>
    <org_study_id>R-06-542</org_study_id>
    <nct_id>NCT00788463</nct_id>
  </id_info>
  <brief_title>A Comparison of Beclomethasone Aqueous Spray and Aerosol Delivery Systems in Nasal Polyps</brief_title>
  <official_title>A Comparison of Beclomethasone Aqueous Spray and Aerosol Delivery Systems in Nasal Polyps</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lawson Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lawson Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if intranasal Beclomethasone delivered by aerosol
      or spray is more effective in treatment of nasal polyps.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aqueous and aerosol delivery of intranasal corticosteroids has never been directly compared
      previously in patients with nasal polyps and it is unknown whether one is superior.

      This objective of this study is to compare the efficacy of intranasal beclomethasone by two
      different delivery systems, aerosol and aqueous spray in patients with nasal polyps. Primary
      endpoint is the difference in the overall quality of life as measured by the Rhinitis Quality
      of Life Questionnaire. The secondary endpoint is the change in Nasal Airflow Resistance as
      measured by rhinomanometry.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 23, 2006</start_date>
  <completion_date type="Actual">November 30, 2011</completion_date>
  <primary_completion_date type="Actual">March 30, 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in overall quality of life as measured by the Rhinitis Quality of Life Questionnaire</measure>
    <time_frame>0, 1, 3, 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference in Nasal Airflow Resistance as measured an anterior rhinomanometry</measure>
    <time_frame>0, 1, 3, 6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Nasal Polyps</condition>
  <arm_group>
    <arm_group_label>Aerosol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Spray</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intranasal Beclomethasone aerosol</intervention_name>
    <description>Beclomethasone aerosol intranasal, 100ug each nostril, twice daily for 6 months.</description>
    <arm_group_label>Aerosol</arm_group_label>
    <other_name>QVAR</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intranasal Beclomethasone spray</intervention_name>
    <description>Beclomethasone spray intranasal, 100ug each nostril, twice daily for 6 months.</description>
    <arm_group_label>Spray</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years old

          -  New diagnosis of nasal polyps confirmed by two physicians

        Exclusion Criteria:

          -  Intranasal corticosteroid use within 4 weeks

          -  Oral corticosteroids use within 4 weeks

          -  Oral corticosteroid inhalation (ie for treatment of asthma or COPD) of Budesonide
             &gt;400ug daily, Fluticasone &gt;250ug daily, Beclomethasone &gt;400ug daily

          -  Contraindication to intranasal corticosteroid

          -  Inability to give informed consent

          -  Participation in another clinical trial

          -  Pregnancy (or not using effective method of contraception) or lactation

          -  Cystic fibrosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jorge A Mazza, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Western Ontario, Canada</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Allergy Clinic, London Health Sciences Centre</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>SILCOX LE. The intranasal use of hydrocortisone alcohol. AMA Arch Otolaryngol. 1954 Oct;60(4):431-9.</citation>
    <PMID>13196789</PMID>
  </reference>
  <reference>
    <citation>SMITH RE. DEXAMETHASONE NASAL AEROSOL IN NASAL POLYPS AND HYPERTROPHIC ALLERGIC RHINITIS: A CLINICAL AND CONTROLLED EVALUATION. Ann Allergy. 1965 Jun;23:273-6.</citation>
    <PMID>14308145</PMID>
  </reference>
  <reference>
    <citation>Taub SJ. Dexamethasone nasal aerosol vs. placebo in the treatment of nasal polyposis. Eye Ear Nose Throat Mon. 1968 Aug;47(8):392-5.</citation>
    <PMID>4891434</PMID>
  </reference>
  <reference>
    <citation>Norman PS, Winkenwerder WL, Agbayani BF, Migeon CJ. Adrenal function during the use of dexamethasone aerosols in the treatment of ragweed hay fever. J Allergy. 1967 Jul;40(1):57-61.</citation>
    <PMID>5230040</PMID>
  </reference>
  <reference>
    <citation>Mygind N, Hansen I. Beclomethasone dipropionate aerosol effect on the adrenals in normal persons. Acta Allergol. 1973 Sep;28(3):211-8.</citation>
    <PMID>4800886</PMID>
  </reference>
  <reference>
    <citation>Mygind N, Pedersen CB, Prytz S, Sørensen H. Treatment of nasal polyps with intranasal beclomethasone dipropionate aerosol. Clin Allergy. 1975 Jun;5(2):159-64.</citation>
    <PMID>1095246</PMID>
  </reference>
  <reference>
    <citation>Sorensen H, Mygind N, Pedersen CB, Prytz S. [Long-term treatment of nasal polyps with beclomethasone dipropionate aerosol. III. Morphological studies and conclusions]. Acta Otolaryngol. 1976 Sep-Oct;82(3-4):260-2.</citation>
    <PMID>790892</PMID>
  </reference>
  <reference>
    <citation>Pedersen CB, Mygind N, Sorensen H, Prytz S. Long-term treatment of nasal polyps with beclomethasone dipropionate aerosol. II. Clinical results. Acta Otolaryngol. 1976 Sep-Oct;82(3-4):256-9.</citation>
    <PMID>790891</PMID>
  </reference>
  <reference>
    <citation>Mygind N, Sørensen H, Pedersen CB. The nasal mucosa during long-term treatment with beclomethasone dipropionate aerosol. A light-and scanning electron microscopic study of nasal polyps. Acta Otolaryngol. 1978 May-Jun;85(5-6):437-43.</citation>
    <PMID>665215</PMID>
  </reference>
  <reference>
    <citation>Toft A, Wihl JA, Toxman J, Mygind N. Double-blind comparison between beclomethasone dipropionate as aerosol and as powder in patients with nasal polyposis. Clin Allergy. 1982 Jul;12(4):391-401.</citation>
    <PMID>7116616</PMID>
  </reference>
  <reference>
    <citation>Krouse HA, Phung ND, Klaustermeyer WB. Intranasal beclomethasone in severe rhinosinusitis and nasal polyps. Ann Allergy. 1983 Jun;50(6):385-8.</citation>
    <PMID>6344703</PMID>
  </reference>
  <reference>
    <citation>el Naggar M, Kale S, Aldren C, Martin F. Effect of Beconase nasal spray on olfactory function in post-nasal polypectomy patients: a prospective controlled trial. J Laryngol Otol. 1995 Oct;109(10):941-4.</citation>
    <PMID>7499945</PMID>
  </reference>
  <reference>
    <citation>Irifune M, Ogino S, Harada T, Abe Y. Topical treatment of nasal polyps with a beclomethasone dipropionate powder preparation. Auris Nasus Larynx. 1999 Jan;26(1):49-55.</citation>
    <PMID>10077256</PMID>
  </reference>
  <reference>
    <citation>Vidgren MT, Kublik H. Nasal delivery systems and their effect on deposition and absorption. Adv Drug Deliv Rev. 1998 Jan 5;29(1-2):157-177.</citation>
    <PMID>10837586</PMID>
  </reference>
  <reference>
    <citation>Dunn AM, Wilson RS, Baggott PJ. A comparison of beclomethasone dipropionate aqueous nasal spray and beclomethasone dipropionate pressurized nasal spray in the management of seasonal rhinitis. Postgrad Med J. 1984 Jun;60(704):404-6.</citation>
    <PMID>6379630</PMID>
  </reference>
  <reference>
    <citation>Sidwell S. A comparison of the efficacy and tolerance of an aqueous beclomethasone dipropionate nasal spray with the conventional pressurized spray. Curr Med Res Opin. 1983;8(9):659-64.</citation>
    <PMID>6667629</PMID>
  </reference>
  <reference>
    <citation>Harries MG, Anderson PB, Gibson GJ, Hof ZE, Baggott PJ. A comparison of an aqueous and a pressurized nasal spray of beclomethasone dipropionate in the management of seasonal rhinitis. Pharmatherapeutica. 1984;3(9):623-5.</citation>
    <PMID>6374683</PMID>
  </reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 7, 2008</study_first_submitted>
  <study_first_submitted_qc>November 7, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2008</study_first_posted>
  <last_update_submitted>August 25, 2017</last_update_submitted>
  <last_update_submitted_qc>August 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>administration, intranasal</keyword>
  <keyword>aerosol</keyword>
  <keyword>beclomethasone</keyword>
  <keyword>QVAR</keyword>
  <keyword>corticosteroids</keyword>
  <keyword>nasal polyps</keyword>
  <keyword>rhinomanometry</keyword>
  <keyword>Rhinitis Quality of Life Questionnaire</keyword>
  <keyword>Quality of Life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polyps</mesh_term>
    <mesh_term>Nasal Polyps</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Beclomethasone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

